ANTI-CD300F ANTIBODY AND USES THEREOF
    1.
    发明公开

    公开(公告)号:US20240294637A1

    公开(公告)日:2024-09-05

    申请号:US18652625

    申请日:2024-05-01

    IPC分类号: C07K16/28 A61P35/02

    摘要: The present invention relates to an isolated antibody, or antigen binding fragment thereof, which specifically binds to an extracellular domain of CD300f, wherein the antibody, or antigen binding fragment thereof, comprises a heavy chain variable region which comprises: (a) an amino acid sequence that is at least 70% identical to the amino acid sequence represented by SEQ ID NO: 1; and/or (b) a complementarity determining region 1 (CDR1) that comprises the amino acid sequence represented by SEQ ID NO: 2, a complementarity determining region 2 (CDR2) that comprises an amino acid sequence that is represented by SEQ ID NO: 3, and/or a complementarity determining region 3 (CDR3) that comprises an amino acid sequence that is represented by SEQ ID NO: 4, compositions comprising the antibody, antigen binding fragment thereof, and uses for therapy.

    ANTIGEN LOADING
    2.
    发明申请

    公开(公告)号:US20230031629A1

    公开(公告)日:2023-02-02

    申请号:US17782263

    申请日:2020-12-04

    摘要: The disclosure relates to a method of antigen loading an antigen presenting cell or precursor thereof with a target antigen for presentation of the target antigen to a T cell, comprising contacting the antigen presenting cell or precursor thereof with a CD300f binding protein in the presence of the target antigen The disclosure also relates to compositions for antigen loading antigen presenting cells or precursors thereof, to immunoconjugates for antigen loading antigen presenting cells or precursors thereof, and use of antigen-loaded antigen presenting cells and immunoconjugates for promoting or increasing a T cell response to a target antigen in a subject.

    Anti-CD300F antibody and uses thereof

    公开(公告)号:US11987625B2

    公开(公告)日:2024-05-21

    申请号:US16462688

    申请日:2017-11-22

    IPC分类号: C07K16/28 A61P35/02

    摘要: The present disclosure relates to an isolated antibody, or antigen binding fragment thereof, which specifically binds to an extracellular domain of cd300f, wherein the antibody, or antigen binding fragment thereof, comprises a heavy chain variable region which comprises: (a) an amino acid sequence that is at least 70% identical to the amino acid sequence represented by seq id no: 1; and/or (b) a complementarity determining region 1 (cdr1) that comprises the amino acid sequence represented by seq id no: 2, a complementarity determining region 2 (cdr2) that comprises an amino acid sequence that is represented by seq id no: 3, and/or a complementarity determining region 3 (cdr3) that comprises an amino acid sequence that is represented by seq id no: 4, compositions comprising the antibody, antigen binding fragment thereof, and uses for therapy.

    ANTI-CD300F ANTIBODY AND USES THEREOF

    公开(公告)号:US20230063312A1

    公开(公告)日:2023-03-02

    申请号:US16462688

    申请日:2017-11-22

    IPC分类号: C07K16/28 A61P35/02

    摘要: The present disclosure relates to an isolated antibody, or antigen binding fragment thereof, which specifically binds to an extracellular domain of cd300f, wherein the antibody, or antigen binding fragment thereof, comprises a heavy chain variable region which comprises: (a) an amino acid sequence that is at least 70% identical to the amino acid sequence represented by seq id no: 1; and/or (b) a complementarity determining region 1 (cdr1) that comprises the amino acid sequence represented by seq id no: 2, a complementarity determining region 2 (cdr2) that comprises an amino acid sequence that is represented by seq id no: 3, and/or a complementarity determining region 3 (cdr3) that comprises an amino acid sequence that is represented by seq id no: 4, compositions comprising the antibody, antigen binding fragment thereof, and uses for therapy.

    Immunoconjugate
    8.
    发明申请

    公开(公告)号:US20220296727A1

    公开(公告)日:2022-09-22

    申请号:US17631259

    申请日:2020-07-30

    摘要: The present disclosure relates to an immunoconjugate including an antibody, or antigen binding fragment thereof, that specifically binds to CD300f, linked to at least one cytotoxic agent, and to compositions including the immunoconjugate, and use of the immunoconjugate for depleting haematopoietic stem and progenitor cells, for preparing a subject haematopoietic stem cell transplantation, and for the treatment of CD300f associated conditions.